Fluocinolone Acetonide Implant for Patients suffering from chronic posterior non-infectious Uveitis

被引：0
|
作者：
Bitzer, Michaela
机构：
来源：
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE | 2019年 / 236卷 / 07期
关键词：
D O I：
10.1055/a-0891-6002
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：841 / 841
页数：1
相关论文
共 50 条
  • [21] Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye - evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN(R))
    Bodaghi, Bahram
    Quan Dong Nguyen
    Jaffe, Glenn
    Khoramnia, Ramin
    Pavesio, Carlos
    JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2020, 10 (01)
  • [22] An Injectable Fluocinolone Acetonide Intravitreal Insert Decreases the Incidence of Recurrence in Patients with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye: 12 Month Results
    Jaffe, Glenn J.
    Paggiarino, Dario
    Riedel, Gerald
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [23] The effectiveness of the ILUVIEN® (0.2 μg per day of mg fluocinolone acetonide) implant in the treatment of non-infectious posterior uveitis-12-month outcomes from UAE
    Gurbaxani, Avinash
    Kozak, Igor
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [24] Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment
    Steeples, Laura R.
    Pockar, Sasa
    Jones, Nicholas P.
    Leal, Ines
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 1433 - 1442
  • [25] Real-World Experience of Fluocinolone Acetonide 0.19 mg in the Management of Non-Infectious Uveitis
    Logeswaran, Abison
    Azzopardi, Matthew
    Demir, Bahar
    D'Alonzo, Giulia
    Chong, Yu Jeat
    Addison, Peter
    Pavesio, Carlos
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2024,
  • [26] CALM: A retrospective registry to characterize clinical outcome data for chronic non-infectious posterior segment uveitis patients treated with a 0.18 mg fluocinolone acetonide intravitreal insert
    Seth, Kanika
    Singh, Rishi P.
    Sharma, Sumit
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [27] Treatment of Intractable Posterior Uveitis in Pediatric Patients With the Fluocinolone Acetonide Intravitreal Implant (Retisert)
    Patel, C. C.
    Mandava, N.
    Quiroz-Mercado, H.
    Oliver, S. C.
    Braverman, R.
    Olson, J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [28] Real-world data from patients with chronic diabetic macular edema and non-infectious uveitis related edema treated with intravitreal fluocinolone acetonide
    Bergua, Antonio
    Hohberger, Bettina
    Roger, Melany
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [29] Effectiveness of Triamcinolone Acetonide Injection for the Treatment of Non-infectious Intermediate and Posterior Uveitis
    Ahmed, Iftikhar
    Alvi, Rashid Hassan
    Allah, Maaz
    Saleem, Sarah
    Nizamuddin, Muhammad
    JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2024, 23 (01): : 48 - 52
  • [30] CALM: 24-month safety outcomes from a real-world registry study of patients with chronic non-infectious uveitis affecting the posterior segment treated with the 0.18 mg fluocinolone acetonide intravitreal implant
    Begaj, Tedi
    Faia, Lisa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
12345